Concurrent capecitabine and upper abdominal radiation therapy is well tolerated

We retrospectively evaluated acute toxicity in 88 patients that were treated with capecitabine and concurrent radiotherapy to the upper abdomen. These patients included 28 (32%) with pancreatic adenocarcinoma, 18 (20%) with cholangiocarcinoma, 11 (13%) with ampullary carcinoma, 11 (13%) with other p...

Descripción completa

Detalles Bibliográficos
Autores principales: Das, Prajnan, Wolff, Robert A, Abbruzzese, James L, Varadhachary, Gauri R, Evans, Douglas B, Vauthey, Jean Nicolas, Baschnagel, Andrew, Delclos, Marc E, Krishnan, Sunil, Janjan, Nora A, Crane, Christopher H
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1634749/
https://www.ncbi.nlm.nih.gov/pubmed/17062148
http://dx.doi.org/10.1186/1748-717X-1-41

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1634749/
https://www.ncbi.nlm.nih.gov/pubmed/17062148
http://dx.doi.org/10.1186/1748-717X-1-41

Ejemplares similares